OVERVIEW

Berkeley Advanced Biomaterials, Inc. manufactures high-quality, cost-effective skeletal repair resorbable biomaterials. The company offers the entire range of biologics from synthetics to allografts. Berkeley Advanced Biomaterials is a licensed Tissue Bank that has been accredited by AATB. The Ostetic products (Bi-Ostetic™ and Cem-Ostetic®), are based on hydroxyapatite (HAP) technology. These products are available in granule, block and injectable putty formulations. Ostetic products have been in use both overseas and in the U.S. since 2003.

The company strives to manufacture high-quality, cost-effective synthetic and allograft products for skeletal system repair.

For orders, please send mail to sales@ostetic.com. If you cannot find the information you need on our website, please contact us at info@ostetic.com. Thanks for visiting!

 
NEWS
June 2, 2009
AATB Accreditation. Download certificate >>>
April 21, 2006
Quality System Upgrade to ISO 13485:2003. Download certificate >>>
April 26, 2005
Orthofix in Agreement with Berkeley Advanced Biomaterials >>>
July 6, 2004
Download K053213 Clearance Letter for Tri-OsteticTM >>>
June 14, 2004
Nationwide Launch of New Biomaterial: DyNoss® >>>
February 10, 2004
Download K053213 Clearance Letter for Cem-Ostetic® Bone Injection Kit >>>
January 30, 2003
Berkeley Advanced Biomaterials Granted K053213 Clearance Letter to Market Bi-OsteticTM >>>
January 9, 2003
FDA Issues K053213 Clearance Letter for Berkeley Advanced Biomaterials Cem-Ostetic® >>>
   © Copyright 2010, Berkeley Advanced Biomaterials Inc. All rights reserved.